Novartis Ag (NVS) Minority Interest (2009 - 2026)

Novartis Ag (NVS) has 15 years of Minority Interest data on file, last reported at $415.0 million in Q1 2026.

• Quarterly Minority Interest rose 400.0% year-over-year to $415.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $415.0 million (up 400.0% YoY) and the FY2025 annual result came in at $419.0 million, up 423.75% from the prior year.
• Minority Interest retreated to $415.0 million in Q1 2026 per NVS's latest filing, from $419.0 million in the prior quarter.
• The five-year high for Minority Interest was $422.0 million in Q3 2025, with the low at $69.0 million in Q2 2025.
• Average Minority Interest over 5 years is $152.8 million, with a median of $83.0 million recorded in 2023.
• Year-over-year, Minority Interest jumped 468.18% in 2022 and plunged 59.17% in 2025.
• Novartis Ag's Minority Interest stood at $81.0 million in 2022, then increased by 2.47% to $83.0 million in 2023, then declined by 3.61% to $80.0 million in 2024, then jumped by 423.75% to $419.0 million in 2025, then dropped by 0.95% to $415.0 million in 2026.
• Business Quant data shows NVS's Minority Interest at $415.0 million in Q1 2026, $419.0 million in Q4 2025, and $422.0 million in Q3 2025.